These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


221 related items for PubMed ID: 7818311

  • 1. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion.
    Matsuzaki Y, Shibata K, Yoshioka M, Inoue M, Sekiya R, Onitsuka T, Iwamoto I, Koga Y.
    Ann Thorac Surg; 1995 Jan; 59(1):127-31. PubMed ID: 7818311
    [Abstract] [Full Text] [Related]

  • 2. [Negative pleural cytology after intrapleural perfusion hyperthermo-chemotherapy for malignant pleural effusion].
    Yagi T, Ueda K, Kaneda Y, Sakano H, Tanaka T, Matsuoka T, Sudo M, Hayashi M, Hamano K.
    Kyobu Geka; 2004 Feb; 57(2):107-10. PubMed ID: 14978902
    [Abstract] [Full Text] [Related]

  • 3. Induction of apoptosis by intrapleural perfusion hyperthermo-chemotherapy for malignant pleural mesothelioma.
    Matsuzaki Y, Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T.
    Ann Thorac Cardiovasc Surg; 2008 Jun; 14(3):161-5. PubMed ID: 18577894
    [Abstract] [Full Text] [Related]

  • 4. Intrapleural perfusion hyperthermo-chemotherapy under video-assisted thoracoscopic surgery for malignant pleural dissemination: a case report.
    Watanabe S, Sakasegawa K, Shimokawa S, Kariatsumari K, Nakamura Y, Sakata R.
    Anticancer Res; 2002 Jun; 22(6B):3781-3. PubMed ID: 12552992
    [Abstract] [Full Text] [Related]

  • 5. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.
    Kimura M, Tojo T, Naito H, Nagata Y, Kawai N, Taniguchi S.
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):568-71. PubMed ID: 20093263
    [Abstract] [Full Text] [Related]

  • 6. Pleural perfusion thermo-chemotherapy under VATS: a new less invasive modality for advanced lung cancer with pleural spread.
    Shigemura N, Akashi A, Nakagiri T, Hazama K, Ohta M, Matsuda H.
    Ann Thorac Surg; 2004 Mar; 77(3):1016-21; discussion 1021-2. PubMed ID: 14992917
    [Abstract] [Full Text] [Related]

  • 7. [Intrapleural perfusion hyperthermo-chemotherapy with cisplatin in patients with malignant pleural mesothelioma].
    Sakaguchi H, Kaneko K.
    Nihon Geka Gakkai Zasshi; 2009 Nov; 110(6):348-52. PubMed ID: 19999570
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
    Kang M, Zhou L, Lin P.
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
    [Abstract] [Full Text] [Related]

  • 9. Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis.
    Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Tomita M, Ayabe T, Onitsuka T.
    Ann Thorac Surg; 2004 Nov; 78(5):1769-72. PubMed ID: 15511471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The local hyperthermochemotherapy for pleural carcinomatosis].
    Tsuboi M, Nagai K, Saitoh H, Furukawa K, Konaka C, Kato H, Kawana K, Abe K.
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Aug; 40(8):1195-202. PubMed ID: 1402161
    [Abstract] [Full Text] [Related]

  • 13. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
    Ohta Y, Shimizu Y, Matsumoto I, Watanabe G.
    J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
    [Abstract] [Full Text] [Related]

  • 14. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S, Clementi M, Valenti M, Fiorentini G, Cantore M, Kanavos E, Amicucci G.
    In Vivo; 2006 Mar; 20(6A):715-8. PubMed ID: 17203752
    [Abstract] [Full Text] [Related]

  • 15. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK.
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [Abstract] [Full Text] [Related]

  • 16. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
    Kang MQ, Cao YP, Deng F.
    Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
    [Abstract] [Full Text] [Related]

  • 17. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion.
    Muraoka M, Oka T, Akamine S, Tagawa T, Morinaga M, Inoue M, Yamayoshi T, Hashizume S, Matsumoto K, Hayashi T, Nagayasu T.
    J Surg Oncol; 2006 Mar 15; 93(4):323-9. PubMed ID: 16496367
    [Abstract] [Full Text] [Related]

  • 18. [Surgery and hyperthermic pleural perfusion--a new approach for malignancies with pleural involvement].
    Yellin A, Simansky D, Paley M, Friedman H, Teperberg M, Refaely Y.
    Harefuah; 2002 Apr 15; 141(4):335-9, 411. PubMed ID: 12017884
    [Abstract] [Full Text] [Related]

  • 19. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion.
    SHI Z, HE QY, HUA BJ.
    Chin J Integr Med; 2008 Dec 15; 14(4):257-61. PubMed ID: 19082796
    [Abstract] [Full Text] [Related]

  • 20. Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy in patients with lung cancer. In vitro experiments and preliminary clinical results.
    Ichinose Y, Hara N, Ohta M, Asoh H, Yano T, Maeda K, Yagawa K.
    J Thorac Cardiovasc Surg; 1993 Jun 15; 105(6):1041-6. PubMed ID: 8388966
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.